Paid Clinical Trials in Ventura, CA
Here are the 6 most popular medical studies in paid studies ventura
mRNA-1345 for Respiratory Syncytial Virus
The purpose of the study is to evaluate the reactogenicity, safety, and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine, mRNA-1345, in pregnant women, and safety and immunogenicity in infants born to vaccinated mothers.
Phase 3 Clinical Trials
View 97 phase 3 medical studies.
Placebo +1 More for Progressive Supranuclear Palsy
ORION Trial is a trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of a randomized double blind placebo controlled phase, followed by an optional open-label extension phase.
Clinical Trials With No Placebo
View 97 medical studies that do not have a placebo group.
GLB-001 for Acute Myeloid Leukemia
Study GLB-001-01 is a first-in-human (FIH), Phase 1, open-label, dose escalation and expansion clinical study of GLB-001 in participants with relapsed or refractory acute myeloid leukemia (R/R AML) or in participants with relapsed or refractory higher-risk myelodysplastic syndromes (R/R HR-MDS). The dose escalation part (Phase 1a) of the study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of GLB-001 administered orally. Approximately 24 participants (up to 42 participants) may be enrolled in Phase 1a of the study. The dose expansion part (Phase 1b) will be followed to understand the relationships among dose, exposure, toxicity, tolerability and clinical activity, to identify minimally active dose, and to select the recommended dose(s) for phase 2 study. Up to 24 participants (12 participants per dose level) may be enrolled in Phase 1b of the study.
Paid Clinical Trials
View 97 medical studies that offer remuneration.
View More Paid Studies Ventura Trials
See another 74 many medical studies focused on paid studies ventura.